secwatch.observer — SEC 8-K summary
======================================

Issuer:     Co-Diagnostics, Inc. (CODX)
CIK:        0001692415
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001493152-26-001971
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Co-Diagnostics receives Nasdaq delisting notice; trading to move to OTC Pink effective Jan 14
--------------------------------------------------------------------------------

- Nasdaq Staff determined to delist CODX due to continued non-compliance with minimum bid price rule.
- Trading on Nasdaq suspended from open on Jan 14, 2026; shares expected to trade on OTC Pink under CODX.
- Company plans to request a hearing with Nasdaq Hearings Panel to address bid price deficiency.
- Since Jan 2, 2026 (1-for-30 reverse split effective), bid price closed at or above $1.00; may seek compliance if 10 consecutive days ending Jan 15 show $1.00.
- Prior non-compliance notice Jan 10, 2025; two compliance periods expired Jan 5, 2026 without meeting rule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226001971/0001493152-26-001971-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1692415/000149315226001971/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-001971

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer